VERICEL CORPORATION Investments
VERICEL CORPORATION (VCEL) had Investments of $102.10 million as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Assets
us-gaap:Investments · last filed 2026-07-30
- 2026-06-30: Investments $102.10M.
- 2026-03-31: Investments $101.30M.
- 2025-12-31: Investments $98.80M.
- 2025-09-30: Investments $84.60M.
| Period end | Investments |
|---|---|
| 2026-06-30 | $102.10M 10-Q · filed 2026-07-30 |
| 2026-03-31 | $101.30M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $98.80M 10-K · filed 2026-02-26 |
| 2025-09-30 | $84.60M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $83.70M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $82.80M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $81.60M 10-K · filed 2025-02-27 |
| 2024-09-30 | $80.90M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $78.30M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $77.10M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $65.80M 10-K · filed 2024-02-29 |
| 2023-09-30 | $65.10M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $75.80M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $77.40M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $88.40M 10-K · filed 2023-02-23 |
| 2022-09-30 | $67.50M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $68.40M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $67.70M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $60.80M 10-K · filed 2022-02-24 |
| 2021-09-30 | $64.00M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $64.00M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $51.40M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $66.30M 10-K · filed 2021-02-24 |
| 2020-09-30 | $42.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $25.10M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $37.70M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $52.10M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |